bf/NASDAQ:RVLP_icon.jpeg

COM:RVLPHARMA

RVL Pharmaceuticals

  • Stock

Last Close

0.04

20/10 20:00

Market Cap

3.14M

Beta: -

Volume Today

63.96M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
revenue
218.46M
-
245.75M
12.49%
263.70M
7.31%
240.03M
8.98%
27.76M
88.43%
17.50M
36.96%
49.72M
184.10%
cost of revenue
125.62M
-
125.19M
0.34%
140.08M
11.90%
111.63M
20.31%
3.29M
97.05%
3.62M
9.87%
9.46M
161.36%
gross profit
92.84M
-
120.56M
29.85%
123.62M
2.54%
128.40M
3.87%
24.47M
80.94%
13.88M
43.26%
40.27M
190.03%
selling and marketing expenses
general and administrative expenses
selling general and administrative expenses
65.96M
-
56.95M
13.65%
74.24M
30.35%
93.03M
25.31%
72.82M
21.72%
87.46M
20.10%
81.98M
6.27%
research and development expenses
29.06M
-
42.69M
46.89%
43.69M
2.35%
32.32M
26.03%
13.39M
58.58%
6.93M
48.23%
3.97M
42.77%
other expenses
168.73K
-
-4.52M
2,779.98%
664.39K
114.69%
884K
33.05%
-48K
105.43%
-1.33M
2,677.08%
6.26M
569.77%
cost and expenses
220.64M
-
224.83M
1.90%
258.02M
14.76%
236.98M
8.15%
89.50M
62.23%
98.01M
9.50%
95.40M
2.66%
operating expenses
95.02M
-
99.64M
4.87%
117.94M
18.36%
125.35M
6.29%
86.21M
31.22%
94.39M
9.49%
85.94M
8.95%
interest expense
20.19M
-
29.05M
43.92%
20.79M
28.44%
18.21M
12.41%
4.09M
77.51%
4.02M
1.88%
3.11M
22.60%
ebitda
21.58M
-
62.85M
191.25%
87.92M
39.90%
60.95M
30.67%
-40.76M
166.88%
-73.67M
80.72%
-36.19M
50.88%
operating income
-32.05M
-
-52.07M
62.47%
-98.54M
89.25%
3.94M
103.99%
-61.74M
1,668.65%
-80.51M
30.40%
-45.68M
43.26%
depreciation and amortization
23.59M
-
46.45M
96.95%
81.57M
75.61%
57.02M
30.11%
20.98M
63.21%
6.84M
67.38%
9.49M
38.76%
total other income expenses net
-29.70M
-
-77.51M
160.94%
-103.56M
33.61%
-301.96M
191.59%
-33.05M
89.05%
-2.02M
93.88%
-6.03M
198.02%
income before tax
-52.07M
-
-85.64M
64.49%
-118.66M
38.56%
-298.02M
151.15%
-94.80M
68.19%
-82.53M
12.93%
-51.71M
37.34%
income tax expense
-10.25M
-
-40.49M
295.17%
-8.98M
77.81%
-27.12M
201.90%
-5.78M
78.68%
315K
105.45%
-20K
106.35%
net income
-41.82M
-
-45.15M
7.97%
-109.68M
142.90%
-270.90M
146.99%
-89.01M
67.14%
-82.85M
6.92%
-51.69M
37.61%
weighted average shs out
42.85M
-
42.86M
0.01%
45.28M
5.64%
52.37M
15.66%
60.65M
15.82%
67.35M
11.05%
89.80M
33.32%
weighted average shs out dil
42.85M
-
45.86M
7.02%
45.28M
1.27%
52.37M
15.66%
60.65M
15.82%
67.35M
11.05%
89.80M
33.32%
eps
-0.98
-
-1.05
7.14%
-2.42
130.48%
-5.17
113.64%
-1.47
71.57%
-1.23
16.33%
-0.58
52.85%
epsdiluted
-0.98
-
-0.98
0%
-2.42
146.94%
-5.17
113.64%
-1.47
71.57%
-1.23
16.33%
-0.58
52.85%

All numbers in (except ratios and percentages)